Furthermore, there is evidence that interleukin (IL)-10, a main player in the iTreg defense against allergic reactions, results in B cells switching to IgG4 production to the detriment of IgE promoting the tolerogenic environment [39]. This evidence concerns the gene IGHE and allergic disease.